Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revolutionizing Pediatric Neurophysiology With Magnetoencephalography.

Psychophysiology·2026
Same author

Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren.

Hamostaseologie·2024
Same author

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development.

Blood advances·2020
Same author

Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2020
Same author

Elimination of factor VIII-specific B cells by immunotoxins composed of a single factor VIII domain fused to Pseudomonas exotoxin A.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Prophylaxis re-visited: The potential impact of novel factor and non-factor therapies on prophylaxis.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Related Experiment Video

Updated: Apr 27, 2026

Bioelectric Analyses of an Osseointegrated Intelligent Implant Design System for Amputees
14:31

Bioelectric Analyses of an Osseointegrated Intelligent Implant Design System for Amputees

Published on: July 15, 2009

15.7K

New predictive approaches for ITI treatment.

G D Minno1, E Santagostino, K Pratt

  • 1Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|July 1, 2014
PubMed
Summary

Immune tolerance induction (ITI) therapy for hemophilia A with inhibitors is challenging. New research suggests FVIII gene mutation type predicts ITI success, aiding patient selection and optimizing treatment for better outcomes.

Keywords:
B cell responseF8 mutationsT-cell responseanti-FVIII antibodiesimmune tolerance induction therapythrombin generation assay

More Related Videos

Surgical Bone Implantation Technique for Rat Tibia Models of Diabetes and Osteoporosis
02:08

Surgical Bone Implantation Technique for Rat Tibia Models of Diabetes and Osteoporosis

Published on: July 5, 2024

1.7K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K

Related Experiment Videos

Last Updated: Apr 27, 2026

Bioelectric Analyses of an Osseointegrated Intelligent Implant Design System for Amputees
14:31

Bioelectric Analyses of an Osseointegrated Intelligent Implant Design System for Amputees

Published on: July 15, 2009

15.7K
Surgical Bone Implantation Technique for Rat Tibia Models of Diabetes and Osteoporosis
02:08

Surgical Bone Implantation Technique for Rat Tibia Models of Diabetes and Osteoporosis

Published on: July 5, 2024

1.7K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Immune tolerance induction (ITI) therapy for hemophilia A with inhibitors presents significant challenges for patients and healthcare systems.
  • Optimizing ITI strategies is crucial for preventing and eradicating inhibitors, improving patient quality of life, and reducing economic burdens.

Purpose of the Study:

  • To identify predictors of success in ITI therapy for hemophilia A patients with inhibitors.
  • To investigate the role of FVIII gene mutation type in ITI success.
  • To correlate thrombin generation assay (TGA) results with epitope specificity, FVIII concentrate reactivity, and clinical data in inhibitor patients.

Main Methods:

  • Analysis of data from the Italian ITI Registry on 110 patients who completed ITI therapy.
  • In vitro comparison of inhibitor titres against various FVIII concentrates.
  • Correlation of TGA results with epitope specificity, FVIII concentrate reactivity, and clinical data in the PredictTGA study.

Main Results:

  • Inhibitor titre prior to ITI, historical peak titre, and peak titre on ITI are recognized predictors of success.
  • The type of causative FVIII gene mutation is an independent predictor of ITI success, aiding in patient selection.
  • Inhibitor reactivity varies against different FVIII products, with lower reactivity against concentrates containing von Willebrand factor (VWF).

Conclusions:

  • FVIII gene mutation type is a valuable factor for identifying patients with a good prognosis for ITI.
  • Understanding the immunological response, including T-cell and B-cell involvement, can lead to personalized ITI therapies.
  • Further research correlating TGA, epitope specificity, and clinical data will refine ITI strategies and inhibitor management.